{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:04:51Z","timestamp":1783911891859,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10620-025-09596-6","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:12:05Z","timestamp":1766142725000},"page":"2203-2210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the Impact of Visceral Adiposity and Sarcopenia on Outcomes in Hospitalized Patients with Acute Severe Ulcerative Colitis"],"prefix":"10.1007","volume":"71","author":[{"given":"Prajith Raj","family":"Ramesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Klug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edward V.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"9596_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/gutjnl-2016-313060","volume":"67","author":"D Laharie","year":"2018","unstructured":"Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J et al. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab. Gut. 2018;67:237\u2013243.","journal-title":"Gut."},{"key":"9596_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","volume":"4","author":"LC Dinesen","year":"2010","unstructured":"Dinesen LC, Walsh AJ, Protic MN, Heap G, Cummings F, Warren BF et al. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4:431\u2013437.","journal-title":"J Crohns Colitis."},{"key":"9596_CR3","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/ibd\/izae193","volume":"31","author":"L Chaaban","year":"2024","unstructured":"Chaaban L, Cohen B, Cross RK, Kayal M, Long M, Ananthakrishnan A et al. Predicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter Cohort. Inflamm Bowel Dis. 2024;31:1548\u20131555.","journal-title":"Inflamm Bowel Dis."},{"key":"9596_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.gastha.2023.11.001","volume":"3","author":"J Angkeow","year":"2024","unstructured":"Angkeow J, Rothman A, Chaaban L, Paul N, Melia J. Systematic Review: Outcome Prediction in Acute Severe Ulcerative Colitis. Gastro Hep Adv. 2024;3:260\u2013270.","journal-title":"Gastro Hep Adv."},{"key":"9596_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/codi.12798","volume":"17","author":"Y Li","year":"2015","unstructured":"Li Y, Zhu W, Gong J, Zhang W, Gu L, Guo Z et al. Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn\u2019s disease. Colorectal Dis. 2015;17:225\u2013234.","journal-title":"Colorectal Dis."},{"key":"9596_CR6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/ibd\/izy278","volume":"25","author":"RV Bryant","year":"2019","unstructured":"Bryant RV, Schultz CG, Ooi S, Goess C, Costello SP, Vincent AD et al. Visceral Adipose Tissue Is Associated With Stricturing Crohn\u2019s Disease Behavior, Fecal Calprotectin, and Quality of Life. Inflamm Bowel Dis. 2019;25:592\u2013600.","journal-title":"Inflamm Bowel Dis."},{"key":"9596_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MIB.0000000000000978","volume":"23","author":"KW Van Der Sloot","year":"2017","unstructured":"Van Der Sloot KW, Joshi AD, Bellavance DR, Gilpin KK, Stewart KO, Lochhead P et al. Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn\u2019s Disease. Inflamm Bowel Dis. 2017;23:82\u201388.","journal-title":"Inflamm Bowel Dis."},{"key":"9596_CR8","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/apt.14018","volume":"45","author":"DQ Holt","year":"2017","unstructured":"Holt DQ, Moore GT, Strauss BJ, Hamilton AL, De Cruz P, Kamm MA. Visceral adiposity predicts post-operative Crohn\u2019s disease recurrence. Aliment Pharmacol Ther. 2017;45:1255\u20131264.","journal-title":"Aliment Pharmacol Ther."},{"key":"9596_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cgh.2011.05.005","volume":"9","author":"B Erhayiem","year":"2011","unstructured":"Erhayiem B, Dhingsa R, Hawkey CJ, Subramanian V. Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2011;9:684\u20137 e1.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9596_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/ibd\/izab167","volume":"28","author":"P Gu","year":"2022","unstructured":"Gu P, Chhabra A, Chittajallu P, Chang C, Mendez D, Gilman A et al. Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy. Inflamm Bowel Dis. 2022;28:657\u2013666.","journal-title":"Inflamm Bowel Dis."},{"key":"9596_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1053\/j.gastro.2023.06.036","volume":"165","author":"AJ Yarur","year":"2023","unstructured":"Yarur AJ, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B et al. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. Gastroenterology. 2023;165:963\u201375 e5.","journal-title":"Gastroenterology."},{"key":"9596_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/ecco-jcc\/jjy095","volume":"12","author":"KC Cushing","year":"2018","unstructured":"Cushing KC, Kordbacheh H, Gee MS, Kambadakone A, Ananthakrishnan AN. Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients. J Crohns Colitis. 2018;12:1036\u20131041.","journal-title":"J Crohns Colitis."},{"key":"9596_CR13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041\u20131048.","journal-title":"Br Med J."},{"key":"9596_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u2013495.","journal-title":"Lancet Oncol."},{"key":"9596_CR15","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.clnu.2016.10.004","volume":"36","author":"T Zhang","year":"2017","unstructured":"Zhang T, Ding C, Xie T, Yang J, Dai X, Lv T et al. Skeletal muscle depletion correlates with disease activity in ulcerative colitis and is reversed after colectomy. Clin Nutr. 2017;36:1586\u20131592.","journal-title":"Clin Nutr."},{"key":"9596_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000101827","volume":"27","author":"RN Foley","year":"2007","unstructured":"Foley RN, Wang C, Ishani A, Collins AJ, Murray AM. Kidney function and sarcopenia in the United States general population: NHANES III. Am J Nephrol. 2007;27:279\u2013286.","journal-title":"Am J Nephrol."},{"key":"9596_CR17","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","volume":"75","author":"P Tandon","year":"2021","unstructured":"Tandon P, Montano-Loza AJ, Lai JC, Dasarathy S, Merli M. Sarcopenia and frailty in decompensated cirrhosis. J Hepatol. 2021;75:S147\u2013S162.","journal-title":"J Hepatol."},{"key":"9596_CR18","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ehf2.13255","volume":"8","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang J, Ni W, Yuan X, Zhang H, Li P et al. Sarcopenia in heart failure: a systematic review and meta-analysis. ESC Heart Fail. 2021;8:1007\u20131017.","journal-title":"ESC Heart Fail."},{"key":"9596_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/nu14010044","volume":"14","author":"A Kaluzniak-Szymanowska","year":"2021","unstructured":"Kaluzniak-Szymanowska A, Krzyminska-Siemaszko R, Deskur-Smielecka E, Lewandowicz M, Kaczmarek B, Wieczorowska-Tobis K. Malnutrition, Sarcopenia, and Malnutrition-Sarcopenia Syndrome in Older Adults with COPD. Nutrients. 2021;14:44.","journal-title":"Nutrients."},{"key":"9596_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41430-021-00953-y","volume":"76","author":"X Ge","year":"2022","unstructured":"Ge X, Xia J, Wu Y, Ye L, Liu W, Qi W et al. Sarcopenia assessed by computed tomography is associated with colectomy in patients with acute severe ulcerative colitis. Eur J Clin Nutr. 2022;76:410\u2013418.","journal-title":"Eur J Clin Nutr."},{"key":"9596_CR21","first-page":"082","volume":"4","author":"M Zafer","year":"2022","unstructured":"Zafer M, Zhang H, Dwadasi S, Goens D, Paknikar R, Dalal S et al. A clinical predictive model for one-year colectomy in adults hospitalized for severe ulcerative colitis. Crohns Colitis 360 2022;4:082.","journal-title":"Crohns Colitis 360"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09596-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09596-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09596-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:26:28Z","timestamp":1783909588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09596-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["9596"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09596-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PRR, RPH, WSH, JK, JM, JVT, and AMJ have no disclosures. AV has served on advisory boards for AbbVie, Pfizer, and Ferring and has served as a speaker for AbbVie and Pfizer. EVL has consulted for AbbVie, Abivax, Astellas, Avalo, Biocon, Bristol-Myers Squibb, Celltrion Healthcare, Eli Lilly, Genentech, Gilead, Iota Biosciences, Iterative Health, Janssen, Merck, Morphic, Ono Pharma, Spyre, Takeda, and TR1X Bio; has received research support from AbbVie, Genentech, Gilead, Janssen, Merck, and Takeda; and is a shareholder of Exact Sciences and Moderna.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}